{
  "id": 4721783,
  "title": "Cogent Biosciences director Arlene Morris sells $1.69m shares",
  "url": "https://urgent.news/2026/08/31/cogent-biosciences-director-arlene-morris-sells-1-69m-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-31T21:31:18.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/cogent-biosciences-director-arlene-morris-sells-169m-shares-93CH-4883323"
  },
  "original_language": "en",
  "account": "Cogent Biosciences director Arlene Morris offloaded shares worth approximately $1.69 million on August 27, 2026. The sale was conducted under a pre-established Rule 10b5-1 trading plan, which Morris had put in place on May 28, 2026. The shares were traded at a weighted average price ranging from $37.0925 to $37.5396 per share. Since the sale, the stock price has declined to $34.99, though it has still increased by 189% over the past year. Prior to the shares sale, Morris purchased 45,510 shares through the exercise of fully vested stock options on the same day, incurring a total cost of around $245,497. Despite analysts maintaining a bullish outlook on Cogent Biosciences, with price targets ranging from $45 to $62, the company currently holds liquid assets that surpass its short-term obligations, even though it is operating at a loss.",
  "summary": null,
  "key_points": [
    "Arlene Morris sold $1.69m worth of Cogent Biosciences shares on August 27, 2026.",
    "Sale conducted under pre-established Rule 10b5-1 trading plan.",
    "Stock price declined to $34.99 after the sale, but increased 189% in the past year."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}